Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · November 11, 2024

Real-World Effectiveness of Palbociclib Plus Endocrine Therapy in HR+/HER2− Advanced Breast Cancer

The Oncologist

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Oncologist
Real-world effectiveness of palbociclib plus endocrine therapy in HR+/HER2- advanced breast cancer: final results from the POLARIS trial
Oncologist 2024 Oct 30;[EPub Ahead of Print], D Tripathy, JL Blum, MS Karuturi, S McCune, S Kurian, M Moezi, D Anderson, E Gauthier, Z Zhang, MZ Montelongo, Y Wang, GB Rocque

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading